Windlas Biotech Q2 FY25 Results

Windlas Biotech has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 187.00 Cr
• Quarter-on-Quarter (QoQ) Change: 6.76% (Previous Quarter: Rs. 175.15 Cr )
• Year-on-Year (YoY) Change: 22.49% (Same Quarter Last Year: Rs. 152.67 Cr )

Profitability Metrics

• Net Profit: Rs. 15.66 Cr
• QoQ Profit Change: 16.17% (Previous Quarter: Rs. 13.48 Cr )
• YoY Profit Change: 11.60% (Same Quarter Last Year: Rs. 14.03 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 7.49
• QoQ EPS Change: 15.77% (Previous Quarter: Rs. 6.47)
• YoY EPS Change: 10.96% (Same Quarter Last Year: Rs. 6.75)

Performance Summary

Strong

Windlas Biotech performed strongly overall, but with some differences in growth areas. This shows they're adapting to market changes.

This analysis provides a snapshot of Windlas Biotech's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.